Yuman Lee
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 4
- Clostridium difficile and Clostridium perfringens research 2
- Co-authors
- Vincent H. Tam (2 shared papers)Nishant Prasad (2 shared papers)Taijun Yin (1 shared paper)Kady Phe (1 shared paper)Jessica Cottreau (1 shared paper)William L. Musick (1 shared paper)Ming Hu (1 shared paper)Patrick M. McDaneld (1 shared paper)
- Journals
- Open Forum Infectious Diseases (4 papers)Pharmacy Education (1 paper)American Journal of Health-System Pharmacy (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Journal of the International Association of Providers of AIDS Care (JIAPAC) (1 paper)
- Partner nations
- United StatesTaiwan
In The Last Decade
Yuman Lee
19 papers receiving 565 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 223
- Applied Microbiology and Biotechnology 57
- Infectious Diseases 217
- Pharmacology 192
- Clinical Biochemistry 57
Countries citing papers authored by Yuman Lee
This map shows the geographic impact of Yuman Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuman Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuman Lee more than expected).
Fields of papers citing papers by Yuman Lee
This network shows the impact of papers produced by Yuman Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuman Lee. The network helps show where Yuman Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuman Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 157 | |
| 2 | 2014 | 140 | |
| 3 | 2020 | 107 | |
| 4 | 2015 | 52 | |
| 5 | Bezlotoxumab (Zinplava) for Clostridium Difficile Infection: The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial Infection. | 2017 | 22 |
| 6 | 2019 | 20 | |
| 7 | 2021 | 19 | |
| 8 | Meropenem-Vaborbactam (Vabomere™): Another Option for Carbapenem-Resistant Enterobacteriaceae. | 2019 | 18 |
| 9 | 2019 | 8 | |
| 10 | 2023 | 7 | |
| 11 | 2018 | 6 | |
| 12 | 2020 | 5 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2021 | 2 | |
| 17 | 2021 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2025 | 0 |
About Yuman Lee
Yuman Lee is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 21 papers that have together received 574 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Use and Resistance (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Resistance in Bacteria (3 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Intramuscular injections and effects (2 papers) and Drug-Induced Adverse Reactions (2 papers). The work is most often cited by research in Molecular Medicine (223 citations), Applied Microbiology and Biotechnology (57 citations), Infectious Diseases (217 citations), Pharmacology (192 citations) and Clinical Biochemistry (57 citations). Yuman Lee has collaborated with scholars based in United States and Taiwan. Frequent co-authors include Vincent H. Tam, Nishant Prasad, Taijun Yin, Kady Phe, Jessica Cottreau, William L. Musick, Ming Hu, Patrick M. McDaneld, Yanina Dubrovskaya and Warren E. Rose. Their work appears in journals such as Open Forum Infectious Diseases, Pharmacy Education, American Journal of Health-System Pharmacy, Antimicrobial Agents and Chemotherapy and Journal of the International Association of Providers of AIDS Care (JIAPAC).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.